Home
/
Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM) Technical Analysis
Updated: 2026-03-17 00:41 UTC · Last close: 25.49 (+1.31%)
Beam Therapeutics Inc. (BEAM) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
The latest close for Beam Therapeutics Inc. (BEAM) came in at 25.49 (+1.31%). The chart is sitting below its 50-day average while still holding above the 200-day average, suggesting shorter-term weakness inside a still positive long-term backdrop. 20-day momentum is notably weak at -8.70%, with price remains inside its roughly 52-week range (14.54–35.41), while ATR14 volatility is elevated at roughly 7.55% of price. RSI(14) is 42.4, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side. From a pattern perspective, the main active signal is Double bottom. Near-term structure is defined by support at 25.28 and resistance at 27.50. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 6,000 · Net income: -79.99M · EPS (basic): -0.81. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.
Fundamentals Snapshot
Source: sec
Company
Beam Therapeutics Inc.
Note: This is an algorithmic technical snapshot (not financial advice).